Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Bernstein

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Magnetic Resonance in Medicine|February 4, 2009
MRI contrast using solid-state, B1-distorting, microelectromechanical systems (MEMS) microresonant devices (MRDs)Razvan Ciocan, Robert E Lenkinski, Jonathan Bernstein, et al.
BMC Medical Imaging|September 15, 2020
Sentinel lymph node mapping using ICG fluorescence and cone beam CT - a feasibility study in a rabbit model of oral cancerNidal Muhanna, Harley H L Chan, Catriona M Douglas, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 10, 2023
Consensus of an American College of Allergy, Asthma, and Immunology, American Academy of Allergy, Asthma, and Immunology, and American Thoracic Society workgroup on definition of clinical remission in asthma on treatmentMichael Blaiss, John Oppenheimer, Mark Corbett, et al.
The World Allergy Organization Journal|July 5, 2021
The challenges of chronic urticaria part 1: Epidemiology, immunopathogenesis, comorbidities, quality of life, and managementMario Sánchez-Borges, Ignacio J Ansotegui, Ilaria Baiardini, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 8, 2025
Sleep Disorders in the Allergy-Immunology ClinicAlexandra E Conway, Marylee Verdi, Aikaterini Anagnostou, et al.
The World Allergy Organization Journal|June 18, 2021
The challenges of chronic urticaria part 2: Pharmacological treatment, chronic inducible urticaria, urticaria in special situationsMario Sánchez-Borges, Ignacio J Ansotegui, Ilaria Baiardini, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 21, 2016
Short-term prophylactic use of C1-inhibitor concentrate in hereditary angioedema: Findings from an international patient registryMarkus Magerl, Michael Frank, William Lumry, et al.
The World Allergy Organization Journal|May 16, 2020
Acute asthma management during SARS-CoV2-pandemic 2020Michael Levin, Ignacio J Ansotegui, Jonathan Bernstein, et al.
Expert Opinion on Pharmacotherapy|March 10, 2015
Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gapsJean Bousquet, Claus Bachert, Jonathan Bernstein, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|September 6, 2019
Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled randomized studyH Henry Li, Bruce Zuraw, Hilary J Longhurst, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Magnetic Resonance in Medicine|February 4, 2009
MRI contrast using solid-state, B1-distorting, microelectromechanical systems (MEMS) microresonant devices (MRDs)Razvan Ciocan, Robert E Lenkinski, Jonathan Bernstein, et al.
BMC Medical Imaging|September 15, 2020
Sentinel lymph node mapping using ICG fluorescence and cone beam CT - a feasibility study in a rabbit model of oral cancerNidal Muhanna, Harley H L Chan, Catriona M Douglas, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 10, 2023
Consensus of an American College of Allergy, Asthma, and Immunology, American Academy of Allergy, Asthma, and Immunology, and American Thoracic Society workgroup on definition of clinical remission in asthma on treatmentMichael Blaiss, John Oppenheimer, Mark Corbett, et al.
The World Allergy Organization Journal|July 5, 2021
The challenges of chronic urticaria part 1: Epidemiology, immunopathogenesis, comorbidities, quality of life, and managementMario Sánchez-Borges, Ignacio J Ansotegui, Ilaria Baiardini, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 8, 2025
Sleep Disorders in the Allergy-Immunology ClinicAlexandra E Conway, Marylee Verdi, Aikaterini Anagnostou, et al.
The World Allergy Organization Journal|June 18, 2021
The challenges of chronic urticaria part 2: Pharmacological treatment, chronic inducible urticaria, urticaria in special situationsMario Sánchez-Borges, Ignacio J Ansotegui, Ilaria Baiardini, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 21, 2016
Short-term prophylactic use of C1-inhibitor concentrate in hereditary angioedema: Findings from an international patient registryMarkus Magerl, Michael Frank, William Lumry, et al.
The World Allergy Organization Journal|May 16, 2020
Acute asthma management during SARS-CoV2-pandemic 2020Michael Levin, Ignacio J Ansotegui, Jonathan Bernstein, et al.
Expert Opinion on Pharmacotherapy|March 10, 2015
Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gapsJean Bousquet, Claus Bachert, Jonathan Bernstein, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|September 6, 2019
Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled randomized studyH Henry Li, Bruce Zuraw, Hilary J Longhurst, et al.
Pageof 6